Literature DB >> 15741209

Co-infection by cytomegalovirus and BK polyoma virus in renal allograft, mimicking acute rejection.

Ritambhra Nada1, Man Updesh Singh Sachdeva, Kamal Sud, Vivekanand Jha, Kusum Joshi.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15741209     DOI: 10.1093/ndt/gfh737

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Double trouble: concurrent cytomegalovirus and BK polyomavirus infections in a patient who underwent kidney transplantation.

Authors:  Doo Yee Mah; Aida Azlin; Hemlata Kumari Gnanasegaram; Mohd Zaimi; Rosnawati Yahya
Journal:  Korean J Transplant       Date:  2020-06-30

2.  Development and validation of multiplex real-time PCR assays for rapid detection of cytomegalovirus, Epstein-Barr virus, and polyomavirus BK in whole blood from transplant candidates.

Authors:  Kyung-Ah Hwang; Ji Hoon Ahn; Jae-Hwan Nam
Journal:  J Microbiol       Date:  2018-07-25       Impact factor: 3.422

3.  Frequency of Polyomavirus BK Infection in Kidney Transplant Patients Suspected to Nephropathy.

Authors:  M Pakfetrat; R Yaghobi; Z Salmanpoor; J Roozbeh; S Torabinezhad; S Kadkhodaei
Journal:  Int J Organ Transplant Med       Date:  2015

4.  Transcription enhancers as major determinants of SV40 polyomavirus growth efficiency and host cell tropism.

Authors:  Katharina Schmidt; Simon Keiser; Viola Günther; Oleg Georgiev; Hans H Hirsch; Walter Schaffner; Tobias Bethge
Journal:  J Gen Virol       Date:  2016-04-21       Impact factor: 3.891

5.  BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study.

Authors:  Arturo Blazquez-Navarro; Chantip Dang-Heine; Nicole Wittenbrink; Chris Bauer; Kerstin Wolk; Robert Sabat; Timm H Westhoff; Birgit Sawitzki; Petra Reinke; Oliver Thomusch; Christian Hugo; Michal Or-Guil; Nina Babel
Journal:  EBioMedicine       Date:  2018-07-30       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.